Viz.ai has raised a total of $252 million in funding across multiple rounds, including a $40 million Conventional Debt round in March 2023, a $100 million Series D in April 2022, and a $71 million Series C in March 2021, reaching a $1.2 billion valuation. Founded in 2016 by Chris Mansi and David Golan, the San Francisco-based company develops AI-powered healthcare solutions that accelerate disease detection and care coordination. Backed by investors such as Insight Partners, Tiger Global Management, and Innovation Endeavors, Viz.ai is transforming emergency healthcare workflows worldwide.